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Incubation of human low density lipoprotein (LDL) at 37’C in the presence of human umbilical-vein 
endothe~al cells (EC) causes a time-de~ndent shift in the charge and density of LDL. After intravenous 
injection into rats, native LDL is merely cleared from the circuiation by Kupffer cells while EC-modified 
LDL is rapidly cleared by endothelial liver cells. The uptake of native LDL by Kupffer cells and EC- 
modified LDL by endothelial cells in vivo can be explained by the presence of two different specific 
receptors on these cell types. It is concluded that the liver endothelial cells form an important protection 
against a possible atherogenic action of EC-modified LDL. 
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1. INTRODUCTION 
In the past decade much progress has been made 
in the elucidation of the mechanism by which cells 
endocytose low density lipoprotein (LDL). 
Although the importance of the receptor-mediated 
uptake of LDL is indicated in vitro [II the quan- 
titative contribution of this system to the in vivo 
turnover of LDL ranges from 33 to 66% 121. 
Additional uptake mechanisms for LDL are 
therefore proposed including the involvement of a 
so-called scavenger eceptor [3]. As a substrate for 
this receptor acetylated LDL (acetyl-LDL) has 
been used. However, the in vivo occurrence of 
such a chemically modified form of LDL is ques- 
tionable. A more relevant biological modification 
of LDL can be achieved by incubation of LDL 
with umbilical-vein endothelial cells [4]. To assess 
the relative importance of the different liver cell 
types (parenchym~, Kupffer and endothelial cells) 
in the in vivo uptake of native LDL and biological- 
Abbreviations: BSA, bovine serum albumin; PBS, 
phosphate-buffered saline 
Rat liver Kupffer cell 
ly modified LDL (EC-modified LDL), we injected 
the radiolabell~ lipoproteins into rats and deter- 
mined the cellular uptake. Additional in vitro 
studies were performed to determine to what ex- 
tent the relative importance of the various cell 
types for the in vivo uptake of LDL and EC- 
modified LDL can be explained by the presence of 
specific receptors for these lipoproteins. 
2. MATERIALS AND METHODS 
LDL was isolated by ultracentrifugation and 
tube slicing from the blood of healthy volunteers, 
who had fasted overnight 151. The LDL was im- 
mediately iodinated as in [6]. After extensive 
dialysis against PBS it was stabilized by addition of 
10 mg BSA per ml and dialysed again. Specific ac- 
tivity ranged from 80 to 150 cpm/ng LDL protein. 
The acid-soluble (non-iodine) fraction was less 
than 0.1%. 
EC-modified LDL was prepared by incubating 
confluent umbilical-vein endothelial cells (isolated 
and cultured as in [7]) in medium M-199, 10 g per 
1 BSA and 100,ug ‘251-labelled LDL per ml 
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medium. After the indicated time intervals the Kupffer cell preparation approx. 85%, the rest be- 
medium was aspirated and stored. ing endothelial cells. 
EC-modified LDL, non-incubated LDL and 
LDL incubated in the absence of cells were sub- 
jected to agarose electrophoresis as in [8]. After 
electrophoresis the plate was dried and subjected 
to autoradiography. Fig.1 shows that the LDL in- 
cubated with umbilical-vein endothelial cells for 
increasing periods of time showed increasing elec- 
trophoretic mobility indicating an increase in net 
negative charge. The buoyant density of the LDL 
preparations after incubation with umbilical vein 
endothelial cells shifted from 1.050 g/ml toward a 
mean density of 1.080 g/ml, 
Protein was determined according to [12] with 
BSA as a standard. 
Collagenase (type I) and BSA, fraction V, were 
from Sigma (St. Louis, MO), pronase (B-grade) 
from Calbiochem-Behring (La Jolla, CA), 
metrizamide from Nyegaard & Co A/S (Oslo), 
Ham’s F-10 from Gibco-Europe (Hoofddorp, The 
Netherlands), 1311 and 1251 (carrier-free) in NaOH 
from New England Nuclear (Dreieich). 
3. RESULTS AND DISCUSSION 
In some experiments LDL was acetylated with 
acetic anhydride as in [9]. 
Rat liver endothelial, Kupffer and parenchymal 
cells were isolated from 3-month-old male Wistar 
rats. For in vivo uptake studies cells were isolated 
10 min after intravenous injection of the lipopro- 
tein fractions. The entire isolation procedure was 
performed at a low temperature to prevent 
degradation of endocytosed lipoprotein during cell 
isolation. For in vitro studies, cells were isolated at 
37°C. Both techniques have been detailed in [lo]. 
Native LDL and LDL incubated with umbilical- 
vein endothelial cells for increasing time periods 
were injected into rats. Subsequently serum decay 
and liver uptake were determined. Fig.2A shows 
that the serum decay of LDL is accelerated upon 
prolonged exposure of LDL to umbilical-vein en- 
dothelial cells. 
Incubation of cells was performed in Hams F-10 
medium with the indicated amounts of lipopro- 
teins. Determination of the amount of cell- 
associated lipoprotein was done as in [ 111. The 
viability of cells before and after incubation was 
higher than 95% as judged by the trypan blue ex- 
clusion test. Purity of the cell preparations was 
checked by light microscopy: the endothelial cell 
preparation was more than 95% pure and the 
The kinetics of liver uptake was determined by 
excising a liver lobule at different time intervals 
after injection. After weighing the lobule and 
counting its radioactivity the fraction of the in- 
jected dose present in the liver was calculated using 
the assumption that 3.75% of the total body 
weight is contributed by the liver [ 131. It is evident 
that incubation of LDL for increasing periods of 
time with umbilical-vein endothelial cells increases 
the amount that becomes associated with the liver 
(fig.2B). Furthermore at 10 min after injection the 
amount of lipoprotein cleared from the blood is 
quantitatively recovered in the liver. 
imat- 
hwm 
Fig. 1. Agarose electrophoresis of 1251-labelled EC- 
modified LDL and 1251-labelled control LDL. LDL was 
incubated in the presence or absence of cells for 
increasing time periods. Electrophoresis and autoradio- 
graphy were performed as in [8]. 
Determination of the cell type(s) responsible for 
the in vivo liver uptake was done by isolating the 
various liver cell types 10 min after injection by a 
cold procedure. ‘251-labelled EC-modified LDL 
(incubated for 44 h) was injected simultaneously 
with 1311-labelled native LDL. Fig.3 shows the 
percentage of the injected dose of lipoprotein pre- 
sent in the different isolated cell fractions express- 
ed per mg cell protein. It can be seen that the en- 
dothelial cell fraction contains much more EC- 
modified LDL than the Kupffer cell fraction. This 
becomes even more evident as the approx. 15% 
contamination of the Kupffer cell fraction with en- 
dothelial cells is taken into account. It can be 
calculated that at least 20-times more EC-modified 
LDL becomes associated with the endothelial cells 
150 
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Fig.2. Serum decay (A) and liver uptake (B) after 
injection into rats of control (A) LDL and LDL 
incubated with umbilical-vein endothelial cell for 9 (0), 
23 {r) or 44 h (e). Serum values were dete~ined in the 
20000 x g supernatant of blood samples. Liver uptake 
was determined by excising successively the different 
lobules of the liver followed by weighing of the lobule 
and counting of its radioactivity. 
than with Kupffer cells. Fig.3B shows the in vivo 
uptake of native LDL by the different liver cell 
types. In contrast to EC-modified LDL, the Kupf- 
fer cell fraction contains much more radioactivity 
per mg cell protein than do the endothelial cells. 
With both EC-modified LDL and native LDL 
the endothelial and Kupffer cells contain approx. 
30-times more radioactivity per mg cell protein 
than do the parenchymal cells. This indicates that 
the non-parenchymal cell types have an important 
function in the clearance of both these lipoproteins 
from the blood. 
To determine the respective specificity of the in- 
teraction of EC-modified LDL and native LDL 
with endothelial and Kupffer cells in vitro competi- 
tion experiments were performed. Freshly isolated 
endothelial cells were incubated with ‘251-labelled 
EC-modified LDL and increasing amounts of 
uniabelled acetyl-LDL or native LDL. Fig.4 shows 
that the binding and degradation of EC-modified 
LDL are 80% inhibited at equimolar amounts of 
EC-modified and acetyl-LDL. A similar experi- 
ment but with a 30-fold excess of native LDL 
showed no com~tition (not shown). This indicates 
that EC-modified LDL is specifically recognized 
by a scavenger eceptor on liver endothelial cells 
which also recognizes acetyl-LDL. The presence of 
this receptor was indicated earlier with acetyl-LDL 
as a substrate [lo]. 
The specificity of the intera~ion of native LDL 
with Kupffer cells was determined by incubating 
this cell type with ‘2sI-labelled native LDL and in- 
creasing amounts of unlabelled acetyl and native 
LDL. Fig.5 shows that while the native LDL in- 
hibits cell association by 50%, acetyl-LDL is com- 
pletely ineffective. 
Because it is known that uptake of modified 
(denatured) proteins is likely to occur in the 
reticuloendothelial system (including Kupffer cells) 
we performed experiments to determine to what 
extent denaturation of a part of native human 
LDL during the iodination or prep~ation pro- 
cedures could be responsible for this uptake. It was 
found that previous screening of LDL did not in- 
fluence the serum decay or relative involvement of 
the different liver cell types in the liver uptake. A 
similar lack of screening upon liver uptake and 
serum decay of rat LDL was reported in [I 11. 
Secondly, by simultaneous injection of 12’1- 
labelled LDL and 1311-labelled reductively 
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Fig.3. In vivo uptake of ‘Z’I-labelled EC-modified LDL 
(incubated 44 h) (A) and ‘3LI-iabelled native LDL (B). 
Both lipoproteins were injected intravenously into rats; 
10 min later a cold liver perfusion was started. After 
8 min perfusion a lobule was tied off and excised to 
determine the whole rat liver value (W.R.L.). 
Subsequently endothelial (EC), Kupffer (K.C.) and 
parenchymal cells (P.C.) were isolated. (M.F., mixed 
fraction of endothelial and Kupffer cells.) Values are 
expressed as percentage of injected dose per mg cell 
protein x 10’ (A) or x lo4 (B). 
methylated LDL it was found that half of the 
Kupffer cell uptake can be defined as receptor- 
mediated (after reductive methylation of LDL 
Kupffer cell uptake was half of that obtained with 
native human LDL) (not shown). These results 
show that the Kupffer cell has a specific recogni- 
tion site for LDL which pfays an important role in 
the liver uptake of LDL. 
The increased decay of LDL upon incubation 
with umbilical-vein endothelial cells can be ade- 
quately explained by the increased interaction of 
I I I 
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Fig.4. Competition between i2SI-iabelled EC-modified 
LDL and unlabelled acetyl-LDL for cell association (e) 
and degradation (0) by rat liver endothelial cells. The 
concentration of i251-labelled EC-modified LDL was 
10 gg/ml. Values are given as percentage of the control 
incubated in the absence of acetyl-LDL. 
Volume 171, number 1 FEBSLETTERS June 1984 
% 
loo- 
* 
3 
3 
2 
:: 
ii 50 - 
r: -0 
J 
L 
: 
lo- 
I 
I I 1 
10 25 50 
unlabeled lipoprotein (~giml) 
Fig.5 Competition between ‘251-labelled LDL and 
unlabelled acetyl-LDL (0) or unlabelled LDL (0) for 
cell association with rat liver Kupffer cells. The 
concentration of ‘251-labelled LDL was 6 pg/ml. Values 
are given as percentage of the control incubated solely 
with ‘ZsI-labelled LDL. 
EC-modified LDL with the scavenger eceptor on 
endothelial cells. Modified lipoproteins are con- 
sidered as potentially atherogenic because uptake 
of the particles can lead to accumulation of 
cholesterol esters in cells of the mononuclear 
phagocyte system [3]. The uptake of these abnor- 
mal lipoproteins by macrophages in vivo might ex- 
plain the formation of foam cells in the arterial 
wall [15]. If EC-modified LDL is generated in vivo 
and the modified LDL enters the general circula- 
tion then the liver and in particular liver en- 
dothelial cells will entrap them. In this way the oc- 
currence of potentially atherogenic particles in the 
blood will be prevented. 
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